scispace - formally typeset
R

Rogelio Perez-Padilla

Publications -  3
Citations -  292

Rogelio Perez-Padilla is an academic researcher. The author has contributed to research in topics: Hydroxychloroquine & Randomized controlled trial. The author has an hindex of 3, co-authored 3 publications receiving 84 citations.

Papers
More filters
Journal ArticleDOI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more
TL;DR: In this article, a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients was presented.
Posted ContentDOI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Cathrine Axfors, +101 more
- 22 Oct 2020 - 
TL;DR: It is found that there is no benefit of hydroxychloroquine or chloroquine on the survival of COVID-19 patients, and the confidence interval is compatible with increased mortality or negligibly reduced mortality.
Journal ArticleDOI

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more